IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.924
EU - Europa 8.572
AS - Asia 7.572
SA - Sud America 1.242
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 9
Totale 28.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.729
SG - Singapore 3.287
IE - Irlanda 1.684
UA - Ucraina 1.646
HK - Hong Kong 1.580
IT - Italia 1.247
RU - Federazione Russa 1.063
BR - Brasile 1.053
CN - Cina 1.008
SE - Svezia 800
VN - Vietnam 784
DE - Germania 665
FI - Finlandia 505
KR - Corea 286
GB - Regno Unito 267
TR - Turchia 222
FR - Francia 215
CA - Canada 103
AR - Argentina 79
PL - Polonia 75
IN - India 66
NL - Olanda 60
CH - Svizzera 58
BD - Bangladesh 52
ES - Italia 52
AT - Austria 51
MX - Messico 48
JP - Giappone 46
BE - Belgio 45
ZA - Sudafrica 45
UZ - Uzbekistan 44
EC - Ecuador 28
LB - Libano 27
ID - Indonesia 25
IQ - Iraq 25
CZ - Repubblica Ceca 23
PK - Pakistan 20
GR - Grecia 19
LT - Lituania 19
VE - Venezuela 19
MA - Marocco 18
PY - Paraguay 18
CL - Cile 16
SA - Arabia Saudita 14
EU - Europa 13
RO - Romania 13
MK - Macedonia 12
DZ - Algeria 11
EG - Egitto 11
AZ - Azerbaigian 10
CO - Colombia 10
AL - Albania 9
KE - Kenya 9
IR - Iran 8
PH - Filippine 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
UY - Uruguay 7
BG - Bulgaria 6
KZ - Kazakistan 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
JO - Giordania 5
NP - Nepal 5
PT - Portogallo 5
AU - Australia 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
HN - Honduras 4
HU - Ungheria 4
MY - Malesia 4
PE - Perù 4
PS - Palestinian Territory 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
CI - Costa d'Avorio 3
CU - Cuba 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
IL - Israele 3
LK - Sri Lanka 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
EE - Estonia 2
ET - Etiopia 2
GY - Guiana 2
HR - Croazia 2
IS - Islanda 2
KG - Kirghizistan 2
MG - Madagascar 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
Totale 28.418
Salva come PNG Salva come JPEG
Città #
Singapore 2.010
Chandler 1.785
Dublin 1.673
Hong Kong 1.577
San Mateo 906
Jacksonville 901
Boardman 533
Ashburn 485
Santa Clara 474
Dong Ket 467
Altamura 434
Medford 416
Princeton 415
Perugia 348
Moscow 323
Lawrence 312
Wilmington 291
Seoul 267
Ann Arbor 265
Beijing 243
Des Moines 226
Andover 211
Munich 192
Izmir 191
Los Angeles 155
Saint Petersburg 139
Ho Chi Minh City 135
New York 119
Piscataway 100
São Paulo 92
Helsinki 91
The Dalles 85
Turku 80
Norwalk 76
Hanoi 55
Redmond 55
Dearborn 54
Woodbridge 52
Shanghai 49
San Paolo di Civitate 46
Brussels 44
London 44
Rome 44
Tokyo 43
Dallas 42
Houston 40
Brooklyn 39
Denver 39
Frankfurt am Main 36
Warsaw 36
Chicago 35
Rio de Janeiro 34
Johannesburg 33
Stockholm 31
Nuremberg 28
San Diego 28
Montreal 27
Atlanta 26
Phoenix 26
Belo Horizonte 25
Falkenstein 25
Toronto 25
Chennai 24
Columbus 23
Amsterdam 22
Brasília 22
Poplar 21
Mexico City 20
Milan 20
Orem 20
San Francisco 20
Boston 19
Den Haag 19
Porto Alegre 19
Curitiba 18
Ankara 17
Tashkent 17
Falls Church 16
Guangzhou 16
Ottawa 16
Campinas 15
Manchester 15
Da Nang 14
Olomouc 14
Secaucus 14
Amelia 13
Auburn Hills 13
Haiphong 13
Tianjin 13
Vienna 13
Guayaquil 12
Hải Dương 12
Baghdad 11
Charlotte 11
Narni 11
Valencia 11
Zhengzhou 11
Baku 10
Cairo 10
Changsha 10
Totale 17.673
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 520
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 237
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 165
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 152
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 134
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 133
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 124
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 124
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 122
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 122
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 121
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 120
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 116
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 116
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 114
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 113
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 112
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 112
Beta 1-tubulin in human platelets: not simply a structural cell frame. 110
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 109
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 109
Nitric oxide and its antithrombotic action on the cardiovascular system 108
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 106
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 105
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 105
Platelets are essential for leukocyte recruitment in allergic inflammation. 105
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 104
Effect of substituted stilbenes on platelet function 104
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 104
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 103
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 103
Tardive gestosis: clinical observations. 102
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 101
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 100
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 99
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 99
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 99
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 97
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 97
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 96
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 96
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 96
Allergen induces the migration of platelets to lung tissue in allergic asthma. 96
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 95
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 95
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 93
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 93
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 93
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 93
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 92
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 92
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 92
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 92
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 92
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 90
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 90
Arterite temporale occulta: contributo casistico e revisione della letteratura 90
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 90
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 89
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 89
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 88
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 88
Effect of First Long-Term Training on Whole Blood Count and Blood Clotting Parameters in Thoroughbreds 88
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 87
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 87
Anti-platelet therapy: phosphodiesterase inhibitors. 87
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 86
Choline plasmalogen biosynthesis by transmethylation in human platelets 86
Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH 86
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 86
Anti-platelet treatments in cancer: Basic and clinical research 86
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 85
Effect of different plasma expanders on erythrocyte filterability 85
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 85
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 85
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 84
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 84
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 84
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 84
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 84
[Occult temporal arteritis. Case reports and review of the literature]. 84
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 84
Matrix metalloproteinases and peripheral arterial disease. 83
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. 83
Effects of resveratrol and other wine polyphenols on vascular function: an update. 83
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 83
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 83
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 82
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. 82
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 82
Platelet thromboxane A2 receptor number and function in normal and in hypertensive pregnancy. 81
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 81
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 81
Platelets 80
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. 80
Antithrombotic potential of thromboxane synthase inhibitors: problems and possible solutions 80
Effect of GOFA nanocrystals on human monocyte cyclooxygenase-2. 80
Selective cytochrome c displacement by phosphate and Ca2+ in brain mitochondria 79
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 79
Splenic irradiation versus splenectomy for severe, refractory HIV-related thrombocytopenia: Effects on platelet counts and immunological status 78
Totale 10.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.813
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.764 0 0 0 0 0 135 278 28 396 110 299 518
2021/20223.196 75 630 79 129 104 22 37 998 43 113 416 550
2022/20235.964 462 1.152 97 451 461 684 6 253 2.128 19 161 90
2023/20242.648 138 203 121 41 29 13 1.019 52 220 99 412 301
2024/20255.200 55 556 145 195 684 241 188 409 1.195 311 791 430
2025/20265.601 819 737 604 1.493 1.632 316 0 0 0 0 0 0
Totale 29.285